Finerenone: A Potential Treatment for Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus
Type 2 diabetes mellitus (T2DM) affects an estimated 463 million people worldwide, equivalent to 1 in 11 adults. Moreover, the rapid growth of this disease has resulted in a high incidence of diabetic kidney disease (DKD), which, together with hypertension, is the main cause of chronic kidney diseas...
- Autores:
-
D’Marco, Luis
Puchades, María Jesús
Gandía, Lorena
Forquet, Claudia
Giménez-Civera, Elena
Panizo, Nayara
Reque, Javier
Juan-García, Isabel
Bermúdez, Valmore
Gorriz, José Luis
- Tipo de recurso:
- Fecha de publicación:
- 2021
- Institución:
- Universidad Simón Bolívar
- Repositorio:
- Repositorio Digital USB
- Idioma:
- eng
- OAI Identifier:
- oai:bonga.unisimon.edu.co:20.500.12442/9655
- Palabra clave:
- Chronic kidney disease
cardiovascular diseases
diabetic nephropathies
finerenone
- Rights
- openAccess
- License
- Attribution-NonCommercial-NoDerivatives 4.0 Internacional